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Abstract
For the assessment of glucose tolerance from IVGTT data in Zucker rat, minimal model
methodology is reliable but time- and money-consuming. This study aimed to validate for
the first time in Zucker rat, simple surrogate indexes of insulin sensitivity and secretion
against the glucose-minimal-model insulin sensitivity index (SI) and against first- (Φ1) and
second-phase (Φ2) β-cell responsiveness indexes provided by C-peptide minimal model.
Validation of the surrogate insulin sensitivity index (ISI) and of two sets of coupled insulin-
based indexes for insulin secretion, differing from the cut-off point between phases (FPIR3-
SPIR3, t = 3 min and FPIR5-SPIR5, t = 5 min), was carried out in a population of ten Zucker
fatty rats (ZFR) and ten Zucker lean rats (ZLR). Considering the whole rat population
(ZLR+ZFR), ISI showed a significant strong correlation with SI (Spearman’s correlation
coefficient, r = 0.88; P<0.001). Both FPIR3 and FPIR5 showed a significant (P<0.001) strong
correlation withΦ1 (r = 0.76 and r = 0.75, respectively). Both SPIR3 and SPIR5 showed a sig-
nificant (P<0.001) strong correlation with Φ2 (r = 0.85 and r = 0.83, respectively). ISI is able
to detect (P<0.001) the well-recognized reduction in insulin sensitivity in ZFRs, compared to
ZLRs. The insulin-based indexes of insulin secretion are able to detect in ZFRs (P<0.001)
the compensatory increase of first- and second-phase secretion, associated to the insulin-
resistant state. The ability of the surrogate indexes in describing glucose tolerance in the
ZFRs was confirmed by the Disposition Index analysis. The model-based validation per-
formed in the present study supports the utilization of low-cost, insulin-based indexes for the
assessment of glucose tolerance in Zucker rat, reliable animal model of human metabolic
syndrome.
Introduction
Insulin sensitivity and beta-cell function are tightly interconnected processes in the governed
glucose tolerance [1,2]. To give a coordinated view of glucose disposal, a concomitant
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evaluation of quantitative indexes able to describe both phenomena is required. It is com-
monly acknowledged, indeed, that in the presence of a reduction of insulin sensitivity, glucose
tolerance is maintained into the range of normality until beta-cells are unable to secrete an
increased amount of insulin compensating for such reduction [3].
The investigation of the phenomena involved in the alteration of glucose tolerance is fre-
quently performed in rodent models, among which the Zucker Fatty Rat (ZFR) is one of the
most studied [4]. Interest in the ZFR relies on the fact that it is a well-recognized genetic
model of human metabolic syndrome. This strain of rat is characterized by hyperinsulinaemia,
glucose intolerance and insulin resistance [4,5].
Both in human and animal studies, the gold standard index for the quantification of
insulin sensitivity is computed using the glucose clamp technique [6]. An equivalent esti-
mation of insulin sensitivity [6] can be achieved by the interpretation of intravenous glu-
cose tolerance test (IVGTT) data by minimal model of glucose kinetics (GKMM). With
respect to glucose clamp, IVGTT requires simpler experimental procedures, thus allowing
the wide application of this methodology both in humans [7–9] and in rats [10–12]. How-
ever, application is still limited to the study of quite small populations since running the
GKMM is a non-trivial operation and requires a particular ability of the operator. In
humans, simple surrogate indexes of insulin sensitivity/resistance in non-perturbed condi-
tion have been extensively validated against the gold standard and applied to large popula-
tion studies [13]. However the same indexes have not provided satisfactory outcome in
rodents, showing in rats, as in mice, modest correlation with the reference standard glucose
clamp [14,15]. On the contrary, simple indexes of insulin sensitivity from IVGTT data have
been introduced and validated both in man and in mice [16–18]. These indexes, based on
glucose disappearance rate and on the area under the insulin curve, have never been
adapted in rats.
Insulin secretion has been often quantitatively evaluated in rats and mice through
indexes based on a dynamic (after a glucose perturbation) insulinaemia curve [19]. In par-
ticular, estimation of first-phase insulin response is commonly provided by the AIRG index
(Acute Insulin Response to Glucose) [20,21]. SPIR index (Second-Phase Insulin Response),
based on the area under the curve of insulin, is used to estimate second-phase insulin
response [22], although less frequently. The recent availability in the ZFR of C-peptide data
during an IVGTT allowed a reliable estimation of first- and second-phase insulin secretion
through the definition of a minimal model of C-peptide kinetics (CPMM) [12]. From the
physiological standpoint, C-peptide is preferable to insulin. Indeed, C-peptide is secreted
with insulin in equimolar concentrations from the beta-cells but, differently from insulin, is
not affected by degradation operated by the liver. Despite a greater accuracy in estimating
insulin secretion, the application of a methodology based on C-peptide measurements is
discouraged by the high costs of the C-peptide measurements kits. Furthermore, the
approach with the CPMM suffers the previously mentioned disadvantages of the model-
based procedures. Although insulin-based AIRG and SPIR indexes are commonly applied
both in man and rat, to our knowledge no study has been designed so far to adapt and vali-
date these indexes in rats.
On this basis, the aim of the study is to validate simple surrogate insulin sensitivity and
insulin-based beta-cell function indexes against minimal-model-based indexes, in order to
provide a coordinated assessment of glucose tolerance in the Zucker rat. Validation was per-
formed by direct comparison with insulin sensitivity provided by the GKMM and the first and
second phase beta-cell responsiveness indexes provided by the CPMM.
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CPMM, C-Peptide Kinetics Minimal Model; DI,
Disposition Index; FPIR, First-phase Insulin
Release, i.e. Surrogate First-phase β-cell
responsiveness index; GKMM, Glucose Kinetics
Minimal Model; ISI, Surrogate Insulin sensitivity
index; IVGTT, Intravenous Glucose Tolerance Test;
SI, Insulin sensitivity index derived from GKMM;
SPIR, Second-phase Insulin Release, i.e. Surrogate
Second-phase β-cell responsiveness index; ZFR,
Zucker Fatty Rat; ZLR, Zucker Lean Rat.
Materials and methods
Animals
This study included 20 male Zucker rats (Charles River Laboratories), divided into 2 groups:
a group of 7-to-9week-old homozygous fatty rats (ZFR, fa/fa, n = 10) and a group of age-
matched heterozygous lean rats (ZLR, fa/+, n = 10). All rats were housed in controlled condi-
tions of temperature (21±1˚C), humidity (60±10%) and lighting (08.00–20.00 h) and received
a standard rat chow containing 0.3% sodium, with tap water ad libitum. The experiments were
performed at 08.00 h, after a 12 h overnight fast. The animals were anesthetized with sodium
pentobarbital (50 mgkg-1 i.p., plus maintenance doses if necessary; Sigma Chemical, St. Louis,
Missouri, USA). In our laboratory experience [23] this anaesthetic has shown to be adequate,
since it does not alter insulin secretion, and artefactual dose-dependent effects are not seen.
The adequacy of the anaesthesia was assessed by monitoring the changes in heart rate (HR)
and mean arterial pressure (MAP) and by the state of the pupils. Changes in MAP and HR are
the most valuable indicators of adequacy of the depth of anaesthesia [24]. The onset of instabil-
ity in heart rate and arterial pressure were assumed as indicators of inadequacy of the depth of
anaesthesia.
The experiments were performed in accordance with Italian national guidelines on animal
experimentation (Decreto Legislativo 27/1/1992, no. 116, Attuazione della Direttiva no. 86/
609/CEE in materia di protezione degli animali utilizzati a fini sperimentali o ad altri fini
scientifici). The study was approved by the Ethical committee of IRCCS S. Martino-IST
(Comitato per la sperimentazione etica sugli animali), Genoa, Italy (Permit n. 253). Rectal tem-
perature was controlled and maintained at 37.5±0.5˚C by a heating pad. The right femoral
artery and vein were cannulated. The arterial cannula, connected to a pressure transducer
(Spectramed Statham P23XL, Viggo-Spectramed, Oxnard, California, USA) provided a
recording of AP through a Grass preamplifier, model 7P14A (Grass Instruments, Quincy,
Massachusetts, USA). HR was monitored using a Grass tachograph (model 7P4), triggered by
lead II of the electrocardiogram (ECG). The venous cannula was used for drug injection. AP,
ECG and HR were digitally recorded by an A/D converter (CED Power1401, Cambridge Elec-
tronic Design, Cambridge, UK), stored on a PC and analysed by laboratory software (Spike2,
CED). At the end of the experiments the animals were sacrificed by an overdose of sodium
pentobarbital.
Intravenous Glucose Tolerance Test (IVGTT)
Two basal blood samples (200 μL) were taken from the arterial catheter at –5 and –2 min
before glucose injection. A glucose bolus of 400 mgkg-1 was then injected over 1 min into the
femoral vein (conventional time-zero). The volume of the glucose bolus initially given was
400 μL, that matched the volume withdrawn in the two basal blood samples. Ten additional
blood samples (200 μL) were collected at 1, 2, 3, 5, 8, 15, 25, 40, 70 after the injection, for the
measurement of glucose, insulin and C-peptide concentration. Plasma volume was replaced by
normal saline infusion matching the blood volume withdrawn for the sampling.
Assays
Blood was promptly centrifuged and glucose immediately measured with the glucose oxidase
method using an automated glucose analyser. The remaining plasma was stored at –80˚C for
later insulin determination. Insulin and C-peptide were measured with commercially avail-
able rat insulin and rat C-peptide ELISA kits (Mercodia, Uppsala, Sweden). The sensitivity
of the insulin assay is 11.7 pmolL-1, with an inter-and intra- assay precision of 3.3 and 1.8
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respectively. The sensitivity of the C-peptide assay is 27.5 pmolL-1 with an inter-and intra-
assay precision of 2.9 and 4.4 respectively.
Model-based indexes
Insulin sensitivity. Insulin sensitivity index SI (min
-1/(pmolL-1)) was estimated by apply-
ing the GKMM [25] to fit glucose data. A non-linear least squares estimation technique [26]
implemented in SAAM II software [27] was used. Insulin data were assumed as error-free
model input and were linearly interpolated for the simulation. Errors in glucose measurements
were assumed to be uncorrelated, Gaussian, zero mean. The procedure, has been described in
detail in authors’ previous work [28].
β-cell responsiveness. First- and second-phase β-cell responsiveness indexes, F1 and F2,
were estimated by fitting C-peptide data using the CPMM. Such model was originally intro-
duced for humans by Cobelli and Pacini [29] and adapted for Zucker rats in a recent work by
the authors of the present paper [12].
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F1 ((pmol/L C-peptide)/(mmol/L glucose)) measures the incremental amount of C-pep-
tide, CP0, (per unit volume of compartment 1) released during the first phase of β-cell response
normalized to the maximum increment, ΔG, of plasma glucose concentration after the injec-
tion (defined as the difference between the peak, Gmax, and the steady-state, Gss, value of
plasma glucose concentration). The index F2 (min
-2(pmol/L C-peptide)/(mmol/L glucose))
describes stimulatory effect of glucose concentration on provision into the β-cells and release
of new insulin. This index is expressed as second order partial derivatives of second phase
release, SR2(t), with respect to glucose and time. G(t)–h (mmol/L) is the deviation of plasma
glucose concentration G(t) from a threshold level, h and t is the time interval which follows the
glucose injection.
Secretion parameters γ, and CP0 were estimated in each rat by fitting to measured C-pep-
tide data. A non-linear least squares estimation technique [26] implemented in SAAM II soft-
ware [27] was used. Glucose data were assumed as error-free model input and were linearly
interpolated for the simulation. Errors in C-peptide measurements were assumed to be uncor-
related, Gaussian, zero mean. The responsiveness indexes F1 and F2, were subsequently com-
puted for individual cases. Further details are reported in authors’ previous work [12].
Surrogate indexes
Insulin sensitivity. As shown by Bergman [30], the insulin sensitivity index depends on
the glucose disappearance rate and the suprabasal insulin concentration following the glucose
stimulation. On this basis, a surrogate simple assessment of insulin sensitivity [17,18] could be





where KG is the intravenous glucose tolerance index and AUCD is the mean above-basal area
under insulin curve in the interval 0–70 min. KG was computed as -100b, where b is the slope
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of the logarithm of glucose concentration vs. time in the interval detected as the main elimina-
tion phase (between minute 3 and minute 25). AUCD is computed as the area under the supra-
basal insulin curve (I(t)-I70) according to the trapezoidal rule, divided by the length of the
interval (70 min). Measurement units of ISI are min-1/(pmolL-1).
β-cell responsiveness. First phase insulin release index (FPIR) and second phase insulin
release index (SPIR) were considered for the description of first and second phase secretion,
respectively. Two different formulations for each one of the two empiric indexes were tested, in
relation to the cut-off point assumed for the discrimination of first-phase end and second-phase
beginning. In the first formulation, we considered that first-phase secretion ends 5 minutes
after glucose infusion. Thus, first-phase insulin secretion was calculated as the mean increment
above basal of insulinaemia values measured at 1, 2, 3 and 5 min after intravenous glucose bolus
[20], normalized to fasting glycaemia (FPIR5). SPIR index accounting for the second-phase
insulin responsiveness was computed as the incremental area of insulin from 5 to 70 min after
intravenous glucose bolus, using the trapezoidal rule, normalized to fasting glycaemia (SPIR5).
In the second formulation, as suggested by other authors, the end of the first phase was set 3
minutes after glucose infusion [21]. The corresponding formulation of first-phase insulin
response (FPIR3) was computed as the mean increment above basal of insulinaemia values
measured at 1, 2, and 3 min after intravenous glucose bolus, normalized to fasting glycaemia.
Thus, second-phase insulin responsiveness (SPIR3) was computed as the incremental area of
insulin from 3 to 70 min after intravenous glucose bolus, normalized to fasting glycaemia. The
normalization to fasting glycaemia was performed to obtain indexes of responsiveness more
easily comparable with CPMM indexes (F1 and F2).
Disposition index. In the present study, the following expression [1] of the Disposition
Index (DI) was used for the characterization of glucose tolerance in Zucker rats using surro-
gate indexes:
DI ¼ ISI  FPIR ð4Þ
Statistical analysis
The Lilliefors test was used to evaluate the hypothesis that each data vector or parameter vector
had a normal distribution with unspecified mean and variance. Comparisons between two
groups of normally distributed samples were performed with two-tailed, unpaired Student’s t
test; Wilcoxon rank sum test was used to compare samples which were not normally distrib-
uted. To quantify the linear regression analysis, Pearson’s product-moment correlation coeffi-
cient and Spearman’s rank correlation coefficient were used for normally and non-normally
distributed populations, respectively. Significance level was set at 5%.
To evaluate the degree of agreement between each pair of surrogate and model-based
index, Bland-Altman plots and Lin’s concordance correlation coefficient were computed.
Since surrogate and model-based indexes do not provide the same numerical value, each sur-
rogate index has been corrected by means of the regression curve against the corresponding




Mean or median values for age, body weight, fasting glycaemia, insulinaemia and C-peptide
for the two groups of Zucker rat are reported in Table 1. With respect to age-matched ZLR
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group, the ZFR group shows significantly higher body weight as well as fasting glycaemia, insu-
linaemia and C-peptide.
The average insulinaemia curve for ZLRs and ZFRs is reported in Fig 1. Representative
examples of cut-off point between first- and second-phase secretion at 3rd and 5th minute are
reported in Fig 2A and 2B respectively.
Model-based indexes
Mean or median estimates of model-based insulin sensitivity, and first and second- phase
responsiveness indexes for the two groups of rats are reported in Table 2. On average, SI
showed significantly lower values (83%) in the ZFR group with respect to ZLR group. Indexes
of both first and second-phase responsiveness showed significantly higher median values in
the ZFR group with respect to ZLR group. In particular, the relative increase observed in the
median values was 255% in F1 and 392% in F2.
Table 1. Characteristics of our groups of Zucker rats.
Variable ZLR ZFR Statistics
(n = 10) (n = 10)
Age (wk) 8 [1] 8.4 [1] NS**
BW (g) 230 ± 9 289 ±7 P < 0.001*
Fasting glycaemia (mmolL-1) 4.33 ± 0.28 6.0 ± 0.22 P < 0.001*
Fasting insulinaemia (pmolL-1) 78 [122] 686 ± 115 P < 0.001**
Fasting C-peptide (pmolL-1) 235 [382] 2846 ± 440 P < 0.001**
Values are means ±SE or median [IQR]. ZLR, Zucker Lean Rat; ZFR, Zucker Fatty Rat; BW, body weight; NS, not significant;
* Unpaired Student’s t-test;
** Wilcoxon rank sum test.
doi:10.1371/journal.pone.0173200.t001
Fig 1. Average insulinaemia profiles (± SE) for ZLR (open circles) and ZFR (closed circles) group.
Vertical line represented the cut-off point between first- and second-phase secretion (5th min).
doi:10.1371/journal.pone.0173200.g001
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Fig 2. Insulinaemia profiles for two ZLRs from control population. Vertical line represented the cut-off
point between first- and second-phase secretion (3rd min in panel A and 5th min in panel B).
doi:10.1371/journal.pone.0173200.g002
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Surrogate indexes
Mean or median estimates of surrogate insulin sensitivity, and first and second- phase respon-
siveness indexes for the two groups of rats are reported in Table 3. On average, ISI showed sig-
nificantly lower values (88%) in the ZFR group with respect to ZLR group. Indexes of both
first and second-phase responsiveness showed significantly higher median values in the ZFR
group with respect to ZLR group. In particular, the relative increase observed in the median
values was 333% in FPIR3, 336% in FPIR5, 213% in SPIR3, and 193% in SPIR5. Disposition
index was also computed in each single rat (Fig 3). Significantly lower mean values for DI3 and
DI5 were observed in the ZFR group with respect to ZLR group (Table 3). In particular, the rel-
ative reduction observed in the mean values was 41% in DI3 and 40% in DI5.
Correlation and agreement between model-based and surrogate
indexes
A significant positive linear correlation between ISI and SI values was detected in the whole rat
population (Fig 4, Spearman’s correlation coefficient, r = 0.88 and P < 0.001). The two formu-
lations of FPIR index, FPIR3 and FPIR5 significantly correlated each other (Spearman’s corre-
lation coefficient, r = 0.998 and P < 0.001). Likewise, the correlation between SPIR3 and SPIR5
was very strong and significant (Pearson’s correlation coefficient, r = 0.997 and P< 0.001). A
significant positive linear correlation was detected in the whole rat population between FPIR3
and F1 (Fig 5, panel A, Spearman’s correlation coefficient, r = 0.76 and P < 0.001) and
between SPIR3 and F2 (Fig 5, panel B, Spearman’s correlation coefficient, r = 0.85 and
Table 2. Model-based indexes in ZLR and ZFR groups.
INSULIN SENSITIVITY FIRST-PHASE β-CELL RESPONSIVENESS SECOND-PHASE β-CELL RESPONSIVENESS
SI Φ1 Φ2
ZLR 1.7 [1] (20%) 186 ± 13 (22%) 1.60 [1.47] (37%)
ZFR 0.3 [0.1] (28%) 661 ± 98 (19%) 7.87 ± 0.52 (37%)
Statistics P < 0.001** P < 0.001* P < 0.001**
ZLR, Zucker Lean Rat; ZFR, Zucker Fatty Rat; SI (10
−4min-1/(pmolL-1)); Φ1 ((pmol/L C-peptide)/(mmol/L glucose)); Φ2 (10−1 min-2(pmol/L C-peptide)/
(mmol/L glucose)). Values are reported as means ± SE or as median [IQR]. The percent coefficient of variation of the estimates (CV%) was given in
parentheses.
* Unpaired Student’s t-test;
** Wilcoxon rank sum test.
doi:10.1371/journal.pone.0173200.t002
Table 3. Surrogate indexes in ZLR and ZFR groups.





ISI FPIR3 FPIR5 SPIR3 SPIR5 DI3 DI5
ZLR 1047 ± 118 139 ± 20 119 ± 16 3.1 ± 0.3 2.9 ± 0.3 13.0 ± 1.5 11.2 ± 1.1
ZFR 123 ± 16 602 [161] 519 [144] 9.7 ± 1.0 8.5 ± 0.9 7.7 ± 0.7 6.7 ± 0.6
Statistics P < 0.001* P < 0.001** P < 0.001** P < 0.001* P < 0.001* P < 0.05* P < 0.05*
ZLR, Zucker Lean Rat; ZFR, Zucker Fatty Rat; ISI (10−4min-1/(pmolL-1)); FPIR ((pmol/L insulin)/(mmol/L glucose)); SPIR (105 min(pmol/L insulin)/(mmol/L
glucose)). DI (min-1/(mmol/L glucose)). Values are reported as means ± SE or as median [IQR].
* Unpaired Student’s t-test;
** Wilcoxon rank sum test
doi:10.1371/journal.pone.0173200.t003
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Fig 3. FPIR3 vs ISI (panel A) and FPIR5 vs ISI (panel B) for ZLRs (open circles) and ZFRs (closed
circles). Hyperbolic line was obtained by the best fitting procedure in ZLRs.
doi:10.1371/journal.pone.0173200.g003
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P< 0.001). Similarly, FPIR5 and the corresponding second-phase responsiveness index SPIR5
showed a significant linear correlation with F1 (Fig 6, panel A, Spearman’s correlation coeffi-
cient, r = 0.75 and P < 0.001) and F2 (Fig 6, panel B, Pearson’s correlation coefficient, r = 0.83
and P< 0.001), respectively.
Agreement between each pair of surrogate and model-based indexes, was tested by means
of Lin’s concordance correlation coefficient and Bland-Altman plots. Lin’s concordance corre-
lation coefficient is 0.89 for ISI vs. SI, 0.78 for FPIR vs. F1, and 0.76 for FPIR vs. F2, respec-
tively. Bland-Altman plots are reported in Fig 7 (panels A, B and C). Reported results for
insulin responsiveness surrogate indexes, considered 3rd minute as the cut-off point; similar
results were obtained with cut-off at 5th minute (data not shown).
Discussion
The present study aimed at validating, against minimal-model methodologies, IVGTT-based
indexes for a simple assessment of glucose tolerance in the Zucker Fatty Rat. In order to
exhaustively determine the degree of glucose tolerance, insulin sensitivity should be assessed
in association with beta-cell responsiveness. In the present study, an index (ISI) for the simple
assessment of insulin sensitivity from IVGTT data in rats was evaluated by using an approach
similar to that developed in mice [17], assuming that insulin sensitivity could be provided by
the ratio between KG and insulin AUC during the whole duration of the IVGTT test. ISI was
validated in the whole population by direct comparison with GKMM SI, showing a significant
and strong correlation with the model-based index (Spearman’s correlation coefficient,
r = 0.88, P < 0.001). The elevated value of correlation suggests that ISI is able to provide an
accurate and reliable assessment of insulin sensitivity in the ZFR.
For the evaluation of first-phase secretion the well-known AIRG index (Acute Insulin
Response to Glucose) was considered as a basis. AIRG has been quantified in a variety of ways
Fig 4. Correlation between ISI and SI in the whole rat population (ZLR+ZFR).
doi:10.1371/journal.pone.0173200.g004
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Fig 5. Correlation between FPIR3 andΦ1 (panel A) and between SPIR3 andΦ2 (panel B) in the whole rat
population (ZLR+ZFR).
doi:10.1371/journal.pone.0173200.g005
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Fig 6. Correlation between FPIR5 andΦ1 (panel A) and between SPIR5 andΦ2 (panel B) in the whole
rat population (ZLR+ZFR).
doi:10.1371/journal.pone.0173200.g006
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Fig 7. Bland-Altman plots for corrected ISI and SI (panel A), corrected FPIR3 andΦ1 (panel B),
corrected SPIR3 andΦ2 (panel C). Dashed lines represents limit of agreement (mean ± 1.96 SD).
doi:10.1371/journal.pone.0173200.g007
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in literature. The most common formulation considered the mean value of suprabasal insulin
samples between 1 and 5 min [19,20,31]. A further useful definition considered the mean
value of suprabasal insulin samples between 1 and 3 min [21]. The analysis of the insulinaemia
curve in every single rat, as shown in representative examples in Fig 2, demonstrated that first-
phase end varied within the interval 3–5 minutes. For these reasons, in the present paper both
3rd and 5th minute were tested as cut-off points. Moreover, they were normalized to basal gly-
caemia to obtain FPIR index which have the same units as CPMM-based index F1. FPIR3 and
FPIR5 were validated in the whole population by direct comparison with F1. Significant and
strong correlation with the model-based index were found for both FPIR3 (r = 0.76, P< 0.001)
and FPIR5 (r = 0.75, P < 0.001). Similar correlation with F1 were expected for FPIR3 and
FPIR5 since these two indexes showed a significant strong correlation each other (Pearson’s
correlation coefficient, r = 0.998, P< 0.001). Some authors suggested to normalize AIRG to the
incremental glucose peak [32] but, in our population of Zucker rats, this resulted in a worse
correlation with F1 (results not shown). Recently, a formulation of AIRG between 0 and 4 min-
utes has been proposed as an index of insulin secretion in un-anaesthetized mice [33]. Since
the present IVGTT protocol lacks of the sample at minute 4, at present was not possible to test
performance of this index in Zucker Rat. However, the non-significant difference observed
between FPIR3 and FPIR5 in characterizing insulin secretion, suggested that selecting minute 4
as the cut-off point would not lead to different results.
As for the first-phase, SPIR3 and SPIR5 were validated in the whole population by direct
comparison with model-based index (F2). Significant and strong correlation with F2 were
found for both SPIR3 (r = 0.85, P< 0.001) and SPIR5 (r = 0.83, P < 0.001). Similar correlation
with F2 were expected for SPIR3 and SPIR5 since these two indexes showed a significant strong
correlation each other (Pearson’s correlation coefficient, r = 0.997, P< 0.001). Differently
from first-phase indexes, the units of SPIR3 and SPIR5 are not the same as F2 but normaliza-
tion allows to obtain an index of beta-cell function and not only of insulin release, thus making
the comparison with F2 more appropriate.
The elevated values of correlation between insulin-based and CPMM-based indexes suggest
that FPIR and SPIR indexes are able to provide an accurate and reliable assessment of insulin
secretion in the ZFR. The strong correlation detected between FPIR3 and FPIR5 (r = 0.998,
P< 0.001) and between SPIR3 and SPIR5 (r = 0.997, P< 0.001) indicates that FPIR3-SPIR3
and FPIR5-SPIR5 provide similar information in relation to beta-cell responsiveness to glu-
cose. In an effort to find a standardization of the cut-off sample separating first from second-
phase, FPIR3 and SPIR3 seem to provide slightly better correlations with F1 and F2, respec-
tively. Agreement between each pair of surrogate and model-based indexes was confirmed by
the elevated values of Lin’s concordance correlation coefficient (not lower than 0.76) and by
Bland-Altman plots, as reported in Fig 7.
In the present study, the recognized existence of an insulin-resistant state in ZFR was
confirmed by a significant reduction of ISI with respect to ZLR (123 ± 16 vs. 1047 ± 118
10−4min-1/(pmolL-1), P < 0.001). A concomitant significant increase in beta-cells respon-
siveness was detected in ZFR by means of first-phase (FPIR3 and FPIR5) and second-phase
(SPIR3 and SPIR5) indexes (Table 3). This matches with the well-known presence of hyper-
insulinemia in the ZFR strain [5] and with the enhancement of both first- and second-phase
secretion assessed in ZFR by CPMM interpretation of C-peptide data [12]. The analysis of
glucose tolerance in insulin resistant rats was achieved by laying ZFR sensitivity-secretion
data on the hyperbolic function found in the control group, ZLR (Fig 3). The ZFR sensitiv-
ity-secretion data (closed circles in Fig 3) laid on the early portion of the hyperbolic curve,
indicating a substantial defect in insulin action. However, the distribution of ZFR sensitiv-
ity-secretion data around the hyperbolic curve suggested that hypersecretion was able to
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partially compensate the insulin resistant state. As long as this compensation is adequate,
i.e. the disposition index does not change, the glucose tolerance is not impaired. The present
data (Table 3) showed a significant decrease in mean DI values in ZFRs. This suggested that
the increase of insulin secretion was starting to become inadequate in relation to the degrees
of insulin resistance and glucose intolerance was arising. Nevertheless, glycaemia values
did not overcome the diabetes threshold in ZFR (Table 1) and thus type 2 diabetes did not
develop yet. These results further support the accuracy and reliability of the surrogate
indexes in describing glucose tolerance in Zucker Fatty Rat.
Conclusion
The model-based validation performed in the present study supports the utilization of the sur-
rogate indexes for the assessment of glucose tolerance in the animal model of human meta-
bolic syndrome, the Zucker fatty rat. Results showed, indeed, that the considered indexes are
able to provide an easy, low-cost but accurate assessment of insulin sensitivity and beta-cell
function in the ZFR. Although not intended to replace the minimal-model methodologies,
these indexes offer important advantages in estimating insulin sensitivity and biphasic insulin
secretion in population studies. Since the main advantages over model-based and C-peptide-
based indexes rely on simplicity in computation and lower costs of measurements, these
indexes could be even more suitable in studies over a very large number of animals.
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